Sept 12 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* ST JUDE CHILDREN'S RESEARCH HOSPITAL COMPLETED 1ST STAGE OF ONGOING PHASE I STUDY OF CO'S INVESTIGATIONAL NEW DRUG, GDC-0084
* STUDY HAS DETERMINED AN APPROPRIATE DOSE FOR PAEDIATRIC USE, AND WILL NOW ADVANCE INTO SECOND STAGE